Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 5/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.73 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.62 |
| ▸ | ESR1 | P03372 | 1/20 | 0.59 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | PLOD2 | O00469 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5363082 | 0.91 | LMNA (0.71) | LMNAKMT2ATDP1L3MBTL1MEN1 | |
| SCHEMBL25009812 | 0.89 | L3MBTL1 (0.76) | LMNAKMT2ATDP1L3MBTL1MEN1 | |
| SCHEMBL30556174 | 0.89 | L3MBTL1 (0.76) | LMNAKMT2ATDP1L3MBTL1MEN1 | |
| SCHEMBL25948348 | 0.88 | LMNA (0.64) | LMNAKMT2ATDP1L3MBTL1NPC1 | |
| SCHEMBL17978146 | 0.87 | LMNA (0.65) | LMNAKMT2ATDP1L3MBTL1MEN1 | |
| SCHEMBL25948396 | 0.85 | KMT2A (0.61) | LMNAKMT2ATDP1L3MBTL1NPC1 | |
| Benzyl Nicotinate SCHEMBL24600 | 0.84 | LMNA (1.00) | LMNAKMT2ATDP1L3MBTL1RAB9A | |
| Benzyl Nicotinate SCHEMBL29394048 | 0.84 | LMNA (1.00) | LMNAKMT2ATDP1L3MBTL1RAB9A | |
| SCHEMBL8407977 | 0.84 | LMNA (0.62) | LMNAKMT2ATDP1L3MBTL1NPC1 | |
| Phenethyl Benzoate SCHEMBL168823 | 0.84 | ESR1 (0.80) | LMNAKMT2ATDP1L3MBTL1ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103497713-A | Adhesive composition | CORIUM INT INC | 2014-01-08 | — | — | CN | disclosed |
| CN-103068385-A | C5ar antagonists | CHEMOCENTRYX INC | 2013-04-24 | — | — | CN | disclosed |
| CN-102264227-A | C5ar antagonists | — | 2011-11-30 | — | — | CN | disclosed |
| EP-1911438-A2 | Cosmetic composition containing a derivative of dibenzoylmethane and a arylalkyl amide or ester compound; method of photostabilising the derivative of dibenzoylmethane | L'Oréal (FR) | 2008-04-16 | — | — | EP | disclosed |
| US-20080019930-A1 | Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds | L'OREAL (FR) | 2008-01-24 | — | — | US | disclosed |
| US-20080019930-A1 | Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds | L'OREAL (FR) | 2008-01-24 | — | — | US | disclosed |
| CN-101039706-A | Adhesive composition | CORIUM INTERNAT INC (US) | 2007-09-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080019930-A1 | Dibenzoylmethane sunscreens photostabilized with arylalkyl amide or ester compounds | TYR, DDT, AADAC | LMNA 2641/4885KMT2A 1285/4885TDP1 2051/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.